Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study
Authors:
- Ahmed Abdel-RazikAAAhmed Abdel-Razik
- Rania ElhelalyRERania Elhelaly
- Rasha ElzeheryRERasha Elzehery
- Amany El-DiastyAEAmany El-Diasty
- Sally AbedSASally Abed
- Dina ElhammadyDEDina Elhammady
- Ahmed TawfikATAhmed Tawfik
- 1 May 2016
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 28 (5) , 599-605
Abstract
Hepatocellular carcinoma (HCC) is the third most common cause of cancer mortality among men worldwide. Serotonin is a biogenic amine, which may be involved in the tumorigenesis of HCC. We aimed to determine whether serotonin is a dependable marker for the diagnosis of HCC in cirrhotic patients in comparison with α-fetoprotein protein (AFP) and prothrombin induced by vitamin K absence-II (PIVKA-II). Serum serotonin, AFP, and PIVKA-II were measured in 262 patients with chronic hepatitis C (CHC): 82 cirrhotic patients with HCC (group I), 80 cirrhotic patients without HCC (group II), and 100 CHC-infected patients without cirrhosis (group III); in addition, 60 healthy controls were studied (group IV). AFP showed significant statistical differences among the groups studied (P<0.001). PIVKA-II and serotonin levels showed no statistically significant differences between the patients with CHC group and the healthy controls (P1=0.614 and P1=0.13, respectively), whereas their levels were statistically higher in cirrhotic patients than patients with CHC (all P values <0.001) and in the cirrhotic patients with HCC group than the cirrhotic patients without HCC (P<0.001). A significant positive correlation was found between serum serotonin and AFP (rho=0.794; P<0.001) and serum serotonin and PIVKA-II (rho=0.889; P<0.001) among the patient groups. The receiver operator characteristic curve showed a higher area under the curve for serotonin than AFP and PIVKA-II (0.942, 0.824, and 0.921, respectively). Serotonin may be used together with PIVKA-II to screen for HCC in cirrhotic patients with CHC.Keywords
This publication has 36 references indexed in Scilit:
- Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry ProgramJournal of Cancer Epidemiology, 2014
- Biomarkers for Hepatocellular CarcinomaInternational Journal of Hepatology, 2012
- Hepatocellular CarcinomaNew England Journal of Medicine, 2011
- Hepatitis C virus infection and hepatocarcinogenesisOrvosi Hetilap, 2010
- Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortalityJournal of Viral Hepatitis, 2009
- Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeuticsExpert Review of Gastroenterology & Hepatology, 2009
- Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: A systematic review and meta‐analysisInternational Journal of Cancer, 2008
- Serotonin Regulates Macrophage-Mediated Angiogenesis in a Mouse Model of Colon Cancer AllograftsCancer Research, 2008
- Platelet-Derived Serotonin Mediates Liver RegenerationScience, 2006
- Gene expression in HCV‐associated hepatocellular carcinoma – upregulation of a gene encoding a protein related to the ubiquitin‐conjugating enzymeLiver International, 2003